Rifadin and Cardiac failure - a phase IV clinical study of FDA data

Summary:

Cardiac failure is reported as a side effect among people who take Rifadin (rifampin), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Prednisolone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Cardiac failure when taking Rifadin. It is created by eHealthMe based on reports of 2,091 people who have side effects when taking Rifadin from the FDA, and is updated regularly.

What is Rifadin?

Rifadin has active ingredients of rifampin. eHealthMe is studying from 2,104 Rifadin users. Check the latest studies of Rifadin.

What is Cardiac failure?

Cardiac failure is found to be associated with 2,055 drugs and 2,210 conditions by eHealthMe. Check the latest studies of Cardiac failure.

On Jul, 16, 2026

2,091 people reported to have side effects when taking Rifadin.
Among them, 28 people (1.34%) have Cardiac failure.

Among these 28 people:

How long have people been on Rifadin when they have Cardiac failure? *

What is the gender of people who have Cardiac failure when taking Rifadin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Cardiac failure when taking Rifadin? *

What are other drugs people take besides Rifadin? *

What are other side effects people have besides Cardiac failure? *

Fever: 13 people, 46.43%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 11 people, 39.29%
Diarrhea: 9 people, 32.14%
Gastrointestinal Amyloidosis (amyloid deposits along your gastrointestinal (gi) tract slow down the muscle contractions): 9 people, 32.14%
Staphylococcal Infection (an infection with staphylococcus bacteria): 9 people, 32.14%
Small Intestine Ulcer: 9 people, 32.14%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 9 people, 32.14%
Pleural Effusion (water on the lungs): 9 people, 32.14%
Arrhythmias (irregular heartbeat): 9 people, 32.14%
Blood Urea Increased: 8 people, 28.57%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 42.86%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 4 people, 14.29%
Osteoporosis (bones weak and more likely to break): 4 people, 14.29%
Gastritis (inflammation of stomach): 4 people, 14.29%
Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 3 people, 10.71%
Urination - Excessive At Night: 3 people, 10.71%
Pain: 3 people, 10.71%
Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 3 people, 10.71%
Mycobacterium Avium Complex Infection: 1 person, 3.57%
Lung Infection: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Rifadin and have Cardiac failure?

- Check whether Cardiac failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rifadin:

Rifadin (2,104 reports)

Cardiac failure treatments and more:

Cardiac failure (147,157 reports)

Browse all side effects of Rifadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiac failure:

Cardiac failure (2,055 drugs)

Browse all the conditions that are associated with Cardiac failure:

Cardiac failure (2,210 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rifampin (the active ingredients of Rifadin) and Rifadin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.